Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy

Reproductive BioMedicine Online

Volumn 29, Issue 1, 2014, Pages 94-101

  Srebnik, N ^a,b   Margalioth, E J ^a   Rabinowitz, R ^a,b   Varshaver, I ^a   Altarescu, G ^a,b   Renbaum, P ^a   Levi Lahad, E ^a,b   Weintraub, A ^a,b   Eldar Geva, T ^a,b  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

anti M llerian hormone; antral follicle count; IVF; myotonic dystrophy; ovarian reserve; preimplantation genetic diagnosis

Indexed keywords

CETRORELIX; FOLLITROPIN; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; HYALURONIDASE; MUELLERIAN INHIBITING FACTOR; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ARTICLE; BIRTH RATE; BODY MASS; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; GENETIC SCREENING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIVE BIRTH; METAPHASE; MYOTONIC DYSTROPHY; OOCYTE; OOCYTE RETRIEVAL; OVARIAN RESERVE; OVARY CYCLE; OVARY FOLLICLE; PREGNANCY OUTCOME; PREGNANCY RATE; PREIMPLANTATION EMBRYO; PRENATAL DIAGNOSIS; QUALITY CONTROL; TREATMENT OUTCOME; BLOOD; COMPLICATION; GENETICS; PATHOPHYSIOLOGY; PREGNANCY;

ADULT; ANTI-MULLERIAN HORMONE; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; MYOTONIC DYSTROPHY; OOCYTE RETRIEVAL; OVARIAN RESERVE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PREIMPLANTATION DIAGNOSIS;

EID: 84904057094     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2014.03.013     Document Type: Article

References (33)

1. S.L. Broer, B.W. Mol, D. Hendriks, and F.J. Broekmans The role of antiMüllerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Fertil. Steril. 91 2009 705 714
2. S.L. Broer, M.J. Eijkemans, G.J. Scheffer, I.A. van Rooij, A. de Vet, A.P. Themmen, J.S. Laven, F.H. de Jong, E.R. Te Velde, B.C. Fauser, and F.J. Broekmans Anti-Müllerian hormone predicts menopause: a long-term follow-up study in normoovulatory women J. Clin. Endocrinol. Metab. 96 2011 2532 2539
3. S.L. Broer, J. Van Disseldorp, K.A. Broeze, M. Dolleman, B.C. Opmeer, P. Bossuyt, M.J. Eijkemans, B.W. Mol, and F.J. Broekmans Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach Hum. Reprod. Update 19 2013 26 36
4. J.D. Brook, M.E. McCurrach, H.G. Harley, A.J. Buckler, D. Church, H. Aburatani, K. Hunter, V.P. Stanton, J.P. Thirion, T. Hudson, R. Sohn, B. Zemelman, R.G. Snell, S.A. Rundle, S. Crow, J. Davies, P. Shelbourne, J. Buxton, C. Jones, V. Juvonen, K. Johnson, P.S. Harper, D.J. Shaw, and D.E. Housman Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member Cell 68 1992 799 808
5. Dalton, J.C.; Ranum, L.P.W.; Day, J.W.; 2007. Myotonic dystrophy type 2. Gene Rev. Available from: www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book= gene&part=myotonic-d2 [Initial Posting: September 21, 2006; Last Update: April 23, 2007].
6. T.N. Dao, J. Mathieu, J.P. Bouchard, and M. De Braekeleer Fertility in myotonic dystrophy in Saguenay-Lac-St-Jean: a historical perspective Clin. Genet. 42 1992 234 239
7. M. De Rademaeker, W. Verpoest, M. De Rycke, S. Seneca, K. Sermon, S. Desmyttere, M. Bonduelle, J. Van der Elst, P. Devroey, and I. Liebaers Preimplantation genetic diagnosis for myotonic dystrophy type 1: upon request to child Eur. J. Hum. Genet. 17 2009 1403 1410
8. C. Dechanet, C. Castelli, L. Reyftmann, C. Coubes, S. Hamamah, B. Hedon, H. Dechaud, and T. Anahory Myotonic dystrophy type 1 and PGD: ovarian stimulation response and correlation analysis between ovarian reserve and genotype Reprod. Biomed. Online 20 2010 610 618
9. T. Eldar-Geva, E. Zylber-Haran, R. Babayof, T. Halevy-Shalem, A. Ben-Chetrit, A. Tsafrir, I. Varshaver, B. Brooks, and E.J. Margalioth Similar outcome for cryopreserved embryo transfer following GnRH-antagonist/GnRH- agonist, GnRH-antagonist/HCG or long protocol ovarian stimulation Reprod. Biomed. Online 14 2007 148 154
10. E. Feyereisen, A. Amar, V. Kerbrat, J. Steffann, A. Munnich, M. Vekemans, R. Frydman, and N. Frydman Myotonic dystrophy: does it affect ovarian follicular status and responsiveness to controlled ovarian stimulation? Hum. Reprod. 21 2006 175 182
11. D.K. Gardner, E. Surrey, D. Minjarez, A. Leitz, J. Stevens, and W.B. Schoolcraft Single blastocyst transfer: a prospective randomized trial Fertil. Steril. 81 2004 551 555
12. P.S. Harper, and P.R. Dyken Early-onset dystrophia myotonica. Evidence supporting a maternal environmental factor Lancet 2 1972 53 55
13. M.L. Hortas, J.A. Castilla, and M.T. Gil Decreased sperm function of patients with myotonic muscular dystrophy Hum. Reprod. 15 2000 445 448
14. International Myotonic Dystrophy Consortium New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1) Neurology 54 2000 1218 1221
15. J. Kwee, R. Schats, J. McDonnell, A. Themmen, F. de Jong, and C. Lambalk Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve Fertil. Steril. 90 2008 737 743
16. A. La Marca, G. Sighinolfi, D. Radi, C. Argento, E. Baraldi, A.C. Artenisio, G. Stabile, and A. Volpe Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) Hum. Reprod. Update 16 2010 113 130
17. C. Lavedan, H. Hofmann-Radvanyi, P. Shelbourne, J.P. Rabes, C. Duros, D. Savoy, I. Dehaupas, S. Luce, K. Johnson, and C. Junien Myotonic dystrophy: size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism Am. J. Hum. Genet. 52 1993 875
18. M. Malcov, T. Naiman, D.B. Yosef, A. Carmon, N. Mey-Raz, A. Amit, I. Vagman, and Y. Yaron Preimplantation genetic diagnosis for fragile X syndrome using multiplex nested PCR Reprod. Biomed. Online 14 2007 515 521
19. M.R. Passos-Bueno, A. Cerqueira, M. Vainzof, S.K. Marie, and M. Zatz Myotonic dystrophy: genetic, clinical, and molecular analysis of patients from 41 Brazilian families J. Med. Genet. 32 1995 14 18
20. J. Puymirat, Y. Giguere, J. Mathieu, and J.P. Bouchard Intergenerational contraction of the CTG repeats in 2 families with myotonic dystrophy type 1 Neurology 73 2009 2126
21. J.B. Redman, R.G. Fenwick Jr.; Y.H. Fu, A. Pizzuti, and C.T. Caskey Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring J. Am. Med. Assoc. 21 1993 1960 1965
22. A.D. Roses, and S.H. Apple Protein kinase activity in erythrocyte ghosts in patients with myotonic muscular dystrophy Proc. Natl. Acad. Sci. USA 70 1973 1855 1859
23. B. Sahu, O. Ozturk, N. Deo, K. Fordham, M. Ranierri, and P. Serhal Response to controlled ovarian stimulation and oocyte quality in women with myotonic dystrophy type I J. Assist. Reprod. Genet. 25 2008 1 5
24. J.J. Stachecki, J. Cohen, and S. Munne Cryopreservation of biopsied cleavage stage human embryos Reprod. Biomed. Online 11 2005 711 715
25. C.V. Steer, C.L. Mills, S.L. Tan, S. Campbell, and R.G. Edwards The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer program Hum. Reprod. 7 1992 117 119
26. A.R. Thornhill, C.E. deDie-Smulders, J.P. Geraedts, J.C. Harper, G.L. Harton, S.A. Lavery, C. Moutou, M.D. Robinson, A.G. Schmutzler, P.N. Scriven, K.D. Sermon, and L. Wilton ESHRE PGD consortium 'Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)' Hum. Reprod. 20 2005 35 48
27. A. Tsafrir, G. Altarescu, E. Margalioth, B. Brooks, P. Renbaum, E. Levy-Lahad, R. Rabinowitz, I. Varshaver, and T. Eldar-Geva PGD for fragile X syndrome: ovarian function is the main determinant of success Hum. Reprod. 25 2010 2629 2636
28. C. Turner, and D. Hilton-Jones The myotonic dystrophies: diagnosis and management: review J. Neurol. Neurosurg. Psychiatry 81 2010 358 367
29. J.A. Vazquez, J.A. Pinies, and P. Martul Hypothalamic-pituitary- testicular function in 70 patients with myotonic dystrophy J. Endocrinol. Invest. 13 2001 375 379
30. I. Verlinsky, and A. Kuliev Micromanipulation and biopsy of polar bodies and blastomeres I.K.A. Verlinsky, Atlas of Preimplantation Genetic Diagnosis vol. 1 2005 Taylor and Francis Abrington, Oxon, UK
31. W. Verpoest, M. De Rademaeker, K. Sermon, M. De Rycke, S. Seneca, E. Papanikolaou, C. Spits, L. Van Landuyt, J. Van der Elst, P. Haentjens, P. Devroey, and I. Liebaers Real and expected delivery rates of patients with myotonic dystrophy undergoing intracytoplasmic sperm injection and preimplantation genetic diagnosis Hum. Reprod. 23 2008 1654 1660
32. W. Verpoest, S. Seneca, M. De Rademaeker, K. Sermon, M. De Rycke, M. De Vos, P. Haentjens, P. Devroey, and I. Liebaers The reproductive outcome of female patients with myotonic dystrophy type 1 (DM1) undergoing PGD is not affected by the size of the expanded CTG repeat tract J. Assist. Reprod. Genet. 27 2010 327 333
33. M.D. Wittenberger, R.J. Hagerman, S.L. Sherman, A. McConkie-Rosell, C.K. Welt, R.W. Rebar, E.C. Corrigan, J.L. Simpson, and L.M. Nelson The FMR1 premutation and reproduction Fertil. Steril. 87 2007 456 465